A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study)

Authors
Category Primary study
JournalTherapeutic Advances in Medical Oncology
Year 2024
This article has no abstract
Epistemonikos ID: 02fc6d2aa027f9a113686955dd3dbc003b448049
First added on: Feb 16, 2025